We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FTC Approves Confidential Changes to BMS’ Divestiture Agreements Related to Otezla
FTC Approves Confidential Changes to BMS’ Divestiture Agreements Related to Otezla
The Federal Trade Commission (FTC) has approved certain modifications to Bristol Meyers Squibb’s (BMS) divestiture agreements as part of the company’s 2019 acquisition of Celgene.